Effect	0	6	O
of	7	9	O
U	10	11	B-Gene_or_gene_product
-	11	12	I-Gene_or_gene_product
995	12	15	I-Gene_or_gene_product
,	15	16	O
a	17	18	O
potent	19	25	O
shark	26	31	B-Organism
cartilage	32	41	B-Tissue
-	41	42	O
derived	42	49	O
angiogenesis	50	62	O
inhibitor	63	72	O
,	72	73	O
on	74	76	O
anti	77	81	O
-	81	82	O
angiogenesis	82	94	O
and	95	98	O
anti	99	103	O
-	103	104	O
tumor	104	109	B-Pathological_formation
activities	110	120	O
.	120	121	O

BACKGROUND	123	133	O
:	133	134	O
A	135	136	O
potent	137	143	O
angiogenesis	144	156	O
inhibitor	157	166	O
,	166	167	O
U	168	169	B-Gene_or_gene_product
-	169	170	I-Gene_or_gene_product
995	170	173	I-Gene_or_gene_product
,	173	174	O
has	175	178	O
been	179	183	O
purified	184	192	O
from	193	197	O
the	198	201	O
cartilage	202	211	B-Tissue
of	212	214	O
the	215	218	O
blue	219	223	B-Organism
shark	224	229	I-Organism
(	230	231	O
Prionace	231	239	B-Organism
glauca	240	246	I-Organism
)	246	247	O
.	247	248	O

U	249	250	B-Gene_or_gene_product
-	250	251	I-Gene_or_gene_product
995	251	254	I-Gene_or_gene_product
is	255	257	O
composed	258	266	O
of	267	269	O
two	270	273	O
single	274	280	O
peptides	281	289	O
with	290	294	O
molecular	295	304	O
mass	305	309	O
of	310	312	O
10	313	315	O
and	316	319	O
14	320	322	O
kDa	323	326	O
,	326	327	O
respectively	328	340	O
.	340	341	O

MATERIALS	342	351	O
AND	352	355	O
METHODS	356	363	O
:	363	364	O
U	365	366	B-Gene_or_gene_product
-	366	367	I-Gene_or_gene_product
995	367	370	I-Gene_or_gene_product
was	371	374	O
designed	375	383	O
to	384	386	O
study	387	392	O
human	393	398	B-Cell
umbilical	399	408	I-Cell
vein	409	413	I-Cell
endothelial	414	425	I-Cell
cell	426	430	I-Cell
(	431	432	O
HUVEC	432	437	B-Cell
)	437	438	O
migration	439	448	O
and	449	452	O
proliferation	453	466	O
in	467	469	O
vitro	470	475	O
and	476	479	O
angiogenesis	480	492	O
induced	493	500	O
by	501	503	O
TNF	504	507	B-Gene_or_gene_product
alpha	508	513	I-Gene_or_gene_product
in	514	516	O
chicken	517	524	B-Organism
chorioallantoic	525	540	B-Multi-tissue_structure
membrane	541	549	I-Multi-tissue_structure
(	550	551	O
CAM	551	554	B-Multi-tissue_structure
)	554	555	O
.	555	556	O

Furthermore	557	568	O
,	568	569	O
we	570	572	O
determined	573	583	O
the	584	587	O
ability	588	595	O
of	596	598	O
U	599	600	B-Gene_or_gene_product
-	600	601	I-Gene_or_gene_product
995	601	604	I-Gene_or_gene_product
to	605	607	O
inhibiting	608	618	O
tumor	619	624	B-Cell
cell	625	629	I-Cell
growth	630	636	O
and	637	640	O
metastasis	641	651	O
.	651	652	O

RESULTS	653	660	O
:	660	661	O
U	662	663	B-Gene_or_gene_product
-	663	664	I-Gene_or_gene_product
995	664	667	I-Gene_or_gene_product
(	668	669	O
15	669	671	O
and	672	675	O
30	676	678	O
micrograms	679	689	O
/	689	690	O
ml	690	692	O
)	692	693	O
markedly	694	702	O
inhibited	703	712	O
HUVEC	713	718	B-Cell
migration	719	728	O
and	729	732	O
,	732	733	O
at	734	736	O
15	737	739	O
-	739	740	O
50	740	742	O
micrograms	743	753	O
/	753	754	O
ml	754	756	O
produced	757	765	O
a	766	767	O
dose	768	772	O
-	772	773	O
dependent	773	782	O
decline	783	790	O
in	791	793	O
[	794	795	O
3H	795	797	O
]	797	798	O
-	798	799	O
thymidine	799	808	B-Drug_or_compound
incorporation	809	822	O
.	822	823	O

30	824	826	O
and	827	830	O
50	831	833	O
micrograms	834	844	O
/	844	845	O
ml	845	847	O
of	848	850	O
U	851	852	B-Gene_or_gene_product
-	852	853	I-Gene_or_gene_product
995	853	856	I-Gene_or_gene_product
,	856	857	O
when	858	862	O
added	863	868	O
to	869	871	O
TNF	872	875	B-Gene_or_gene_product
alpha	876	881	I-Gene_or_gene_product
-	881	882	O
induced	882	889	O
angiogenesis	890	902	O
caused	903	909	O
discontinuous	910	923	O
and	924	927	O
disrupted	928	937	O
blood	938	943	B-Multi-tissue_structure
vessels	944	951	I-Multi-tissue_structure
.	951	952	O

Moreover	953	961	O
,	961	962	O
U	963	964	B-Gene_or_gene_product
-	964	965	I-Gene_or_gene_product
995	965	968	I-Gene_or_gene_product
(	969	970	O
30	970	972	O
micrograms	973	983	O
/	983	984	O
ml	984	986	O
)	986	987	O
markedly	988	996	O
prevented	997	1006	O
collagenase	1007	1018	B-Gene_or_gene_product
-	1018	1019	O
induced	1019	1026	O
collagenolysis	1027	1041	O
.	1041	1042	O

In	1043	1045	O
addition	1046	1054	O
,	1054	1055	O
when	1056	1060	O
200	1061	1064	O
micrograms	1065	1075	O
U	1076	1077	B-Gene_or_gene_product
-	1077	1078	I-Gene_or_gene_product
995	1078	1081	I-Gene_or_gene_product
was	1082	1085	O
injected	1086	1094	O
i	1095	1096	O
.	1096	1097	O
p	1097	1098	O
.	1098	1099	O
into	1100	1104	O
mice	1105	1109	B-Organism
it	1110	1112	O
suppressed	1113	1123	O
sarcoma	1124	1131	B-Cell
-	1131	1132	I-Cell
180	1132	1135	I-Cell
cell	1136	1140	I-Cell
growth	1141	1147	O
and	1148	1151	O
B16	1152	1155	B-Cell
-	1155	1156	I-Cell
F10	1156	1159	I-Cell
mouse	1160	1165	I-Cell
melanoma	1166	1174	I-Cell
cell	1175	1179	I-Cell
metastasis	1180	1190	O
in	1191	1193	O
vivo	1194	1198	O
.	1198	1199	O

CONCLUSIONS	1200	1211	O
:	1211	1212	O
These	1213	1218	O
results	1219	1226	O
suggest	1227	1234	O
that	1235	1239	O
the	1240	1243	O
anti	1244	1248	O
-	1248	1249	O
angiogenic	1249	1259	O
effects	1260	1267	O
of	1268	1270	O
U	1271	1272	B-Gene_or_gene_product
-	1272	1273	I-Gene_or_gene_product
995	1273	1276	I-Gene_or_gene_product
may	1277	1280	O
be	1281	1283	O
be	1284	1286	O
due	1287	1290	O
to	1291	1293	O
interference	1294	1306	O
with	1307	1311	O
the	1312	1315	O
proliferation	1316	1329	O
and	1330	1333	O
migration	1334	1343	O
of	1344	1346	O
HUVECs	1347	1353	B-Cell
as	1354	1356	O
well	1357	1361	O
as	1362	1364	O
inhibition	1365	1375	O
of	1376	1378	O
collagenolysis	1379	1393	O
,	1393	1394	O
thereby	1395	1402	O
leading	1403	1410	O
to	1411	1413	O
inhibition	1414	1424	O
of	1425	1427	O
both	1428	1432	O
angiogenesis	1433	1445	O
and	1446	1449	O
tumor	1450	1455	B-Cell
cell	1456	1460	I-Cell
growth	1461	1467	O
.	1467	1468	O

